{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:43:03Z","timestamp":1790023383813,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4S","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.juro.2009.05.099","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:17:35Z","timestamp":1251368255000},"page":"2033-2039","source":"Crossref","is-referenced-by-count":35,"title":["Double Anticholinergic Therapy for Refractory Overactive Bladder"],"prefix":"10.1097","volume":"182","author":[{"given":"St\u00e9phane","family":"Bolduc","sequence":"first","affiliation":[{"name":"Division of Urology, Centre Hospitalier Universitaire de Qu\u00e9bec, Universit\u00e9 Laval, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Moore","sequence":"additional","affiliation":[{"name":"Division of Urology, Centre Hospitalier Universitaire de Qu\u00e9bec, Universit\u00e9 Laval, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lebel","sequence":"additional","affiliation":[{"name":"Division of Urology, Centre Hospitalier Universitaire de Qu\u00e9bec, Universit\u00e9 Laval, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Lamontagne","sequence":"additional","affiliation":[{"name":"Division of Urology, Centre Hospitalier Universitaire de Qu\u00e9bec, Universit\u00e9 Laval, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline","family":"Hamel","sequence":"additional","affiliation":[{"name":"Division of Urology, Centre Hospitalier Universitaire de Qu\u00e9bec, Universit\u00e9 Laval, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2009.05.099_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2165\/00003088-200342140-00004","article-title":"Clinical pharmacokinetics of drugs used to treat urge incontinence","volume":"42","author":"Guay","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.juro.2009.05.099_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.urology.2004.09.036","article-title":"Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?","volume":"65","author":"Yucel","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.05.099_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1464-410X.2003.04085.x","article-title":"The use of tolterodine in children after oxybutynin failure","volume":"91","author":"Bolduc","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2009.05.099_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.clinthera.2006.09.017","article-title":"Solifenacin succinate for the treatment of symptoms of overactive bladder","volume":"28","author":"Maniscalco","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.juro.2009.05.099_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.juro.2008.03.033","article-title":"Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children","volume":"180","author":"Roth","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.mou.0000172401.92761.86","article-title":"Botulinum toxin injections for paediatric incontinence","volume":"15","author":"Schurch","year":"2005","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society","volume":"176","author":"Neveus","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/01.ju.0000157685.83573.79","article-title":"The effect of oxybutynin treatment on cognition in children with diurnal incontinence","volume":"173","author":"Sommer","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/nau.20507","article-title":"The effects of anticholinergic drugs on attention span and short-term memory skills in children","volume":"27","author":"Giramonti","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2009.05.099_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.urology.2007.01.049","article-title":"Initial trial of timed voiding is warranted for all children with daytime incontinence","volume":"69","author":"Allen","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.05.099_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0022-5347(05)67934-7","article-title":"The overactive bladder in childhood: long-term results with conservative management","volume":"163","author":"Curran","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/01.ju.0000155248.57049.4e","article-title":"Metabolic consequences and long-term complications of enterocystoplasty in children: a review","volume":"173","author":"Gilbert","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11934-007-0066-9","article-title":"A review of metabolic consequences and long-term complications of enterocystoplasty in children","volume":"8","author":"Hensle","year":"2007","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2009.05.099_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0022-5347(05)00672-5","article-title":"Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk","volume":"175","author":"Metcalfe","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpurol.2008.06.003","article-title":"Long-term follow up of enteric bladder augmentations: the risk for malignancy","volume":"4","author":"Husmann","year":"2008","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib16","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.ju.0000154891.40110.08","article-title":"Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease","volume":"173","author":"Blaivas","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.juro.2008.05.056","article-title":"Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review","volume":"180","author":"Guerra","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","article-title":"Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects","volume":"53","author":"Amend","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.05.099_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14740338.7.4.473","article-title":"Safety of anticholinergics in patients with benign prostatic hyperplasia","volume":"7","author":"Athanasopoulos","year":"2008","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709013810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709013810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.05.099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:52:39Z","timestamp":1651197159000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.05.099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":19,"journal-issue":{"issue":"4S","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1016\/j.juro.2009.05.099"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.05.099","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}